Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation:: a randomized, placebo-controlled, double-blind study in healthy volunteers

被引:56
|
作者
Köhler, S [1 ]
Funk, P [1 ]
Kieser, M [1 ]
机构
[1] Dr Willmar Schwabe Pharmaceut, Dept Clin Res, D-76227 Karlsruhe, Germany
关键词
bleeding time; coagulation; equivalence; Ginkgo biloba special; extract EGb 761; platelet aggregation;
D O I
10.1097/01.mbc.0000114423.81125.8b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During recent years, several case reports have been published in which the authors have voiced their suspicion of a causal relationship between hemorrhagic complications and the intake of Ginkgo biloba preparations. Therefore, a trial was conducted to investigate the influence of Ginkgo biloba special extract EGb 761 on hemostasiological parameters. Fifty healthy, male volunteers underwent 7 days of crossover treatment with 2 x 120 mg/day EGb 761 and placebo in randomized sequence. Between the two treatment phases, a washout-period of at least 3 weeks was inserted. The study's main outcome measures were bleeding time, coagulation parameters, platelet activity in response to various agonists and platelet morphology. The equivalence of the two treatments was analyzed by computing the 90% Fieller confidence intervals for the ratio between the means of the pre-post treatment differences for EGb 761 and placebo, respectively. Treatment safety was investigated by clinical laboratory and vital signs assessment and by adverse events monitoring. Among the 29 coagulation and bleeding parameters assessed, none showed any evidence of an inhibition of blood coagulation and platelet aggregation through EGb 761. Furthermore, the study did not reveal any evidence to substantiate a causal relationship between the administration of EGb 761 and hemorrhagic complications. As regards treatment tolerability, there were no interpretable differences between EGb 761 and placebo except for a slight increase of gastrointestinal complaints during administration of the herbal extract.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [21] Study protocol of the monocentric prospective randomized placebo-controlled double-blind phase II study to explore the protective effects of the ginkgo biloba extract EGb 761® from temporary noise-induced hearing loss
    Muehlmeier, G.
    Schweikert, A.
    Schramm, S.
    Burkart, M.
    Tisch, M.
    HNO, 2020, 68 (04) : 272 - 277
  • [22] Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients
    Burschka, MA
    Hassan, HAH
    Reineke, T
    van Bebber, L
    Caird, DM
    Mösges, R
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2001, 258 (05) : 213 - 219
  • [23] Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients
    Martin A. Burschka
    Hassan Abdel-Hady Hassan
    Thorsten Reineke
    Lara van Bebber
    David M. Caird
    R. Mösges
    European Archives of Oto-Rhino-Laryngology, 2001, 258 : 213 - 219
  • [24] Placebo-controlled double blind study on the efficacy of Gingko biloba extract EGb 761 in trained patients suffering from intermittent claudication
    Blume, J
    Kieser, M
    Holscher, U
    VASA-JOURNAL OF VASCULAR DISEASES, 1996, 25 (03): : 265 - 274
  • [25] Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial
    Demarin, Vida
    Kes, Vanja Basic
    Trkanjec, Zlatko
    Budisic, Mislav
    Pasic, Marija Bosnjak
    Crnac, Petra
    Budincevic, Hrvoje
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 483 - 490
  • [26] Efficacy and tolerability of Ginkgo biloba extract EGb 761®in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
    Gauthier, Serge
    Schlaefke, Sandra
    CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 2065 - 2077
  • [27] The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects - A double blind placebo-controlled, crossover study
    Blumenthal, Mark
    CLINICAL NUTRITION, 2007, 26 (01) : 164 - 165
  • [28] A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia
    Zhang, XY
    Zhou, DF
    Zhang, PY
    Wu, GY
    Su, JM
    Cao, LY
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (11) : 878 - 883
  • [29] EGb 761(R) Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer's Dementia-Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial
    Kloft, Charlotte
    Hoerr, Robert
    HEALTHCARE, 2021, 9 (12)
  • [30] Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial
    Beck, Stefanie M.
    Ruge, Hannes
    Schindler, Christoph
    Burkart, Martin
    Miller, Robert
    Kirschbaum, Clemens
    Goschke, Thomas
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (03) : 227 - 242